Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment‐naive peripheral T‐cell lymphoma: A multicenter, open‐label, single‐arm, phase 1b trial
The CMOP regimen demonstrates a favorable PK profile, a manageable safety profile, and encouraging preliminary antitumor activity.
Authors
- Yan Gao (ORCID: https://orcid.org/0000-0003-2067-8241)
- Liling Zhang (ORCID: https://orcid.org/0000-0002-0198-2603)
- Yufu Li
- Huiqiang Huang
- Lihong Liu
- Hui Zhou
- Xin Wang
- Xuanye Zhang
- Xiaojing Yan
- Ming Jiang
Institutions
- Hebei Medical University (CN)
- Central South University (CN)
- Sun Yat-sen University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Hunan Cancer Hospital (CN)
- Wuhan Union Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- First Hospital of China Medical University (CN)
- Henan Cancer Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Chongqing Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Cancer
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1002/cncr.70360
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00